Last updated at 10 Jan 2026 06:30 AM
Director
DIN: 07304539
Amol Ramdas Nilakh is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at SYMLUX PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07304539.Amol Ramdas Nilakh has previously been associated with 1 company in roles such as Additional Director.Amol Ramdas Nilakh is currently involved in 2 different roles. Their most recent position is with RASS REALTY LLP as a Designated Partner. The first company Amol Ramdas Nilakh was appointed to as a director was SYMLUX PHARMACEUTICALS PRIVATE LIMITED. Amol Ramdas Nilakh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Amol Ramdas Nilakh is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at SYMLUX PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07304539.Amol Ramdas Nilakh has previously been associated with 1 company in roles such as Additional Director.Amol Ramdas Nilakh is currently involved in 2 different roles. Their most recent position is with RASS REALTY LLP as a Designated Partner. The first company Amol Ramdas Nilakh was appointed to as a director was SYMLUX PHARMACEUTICALS PRIVATE LIMITED. Amol Ramdas Nilakh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (2)
Past Companies (1)
2y 2m 1y 1m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SYMLUX PHARMACEUTICALS PRIVATE LIMITED | Director | 30-Sep-2016 |